Sunesis Pharmaceutic (SNSS) Stock Analyst Ratings
NASDAQ:SNSS - Nasdaq -
ChartMill assigns a Buy % Consensus number of 73% to SNSS. The Buy consensus is the weighted average rating of the current analysts ratings.
SNSS was analyzed by 3 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about SNSS.
In the last month the buy percentage rose by 13 points. So the trust of analysts is improving.
Only 3 analysts analyzed SNSS. So this is just the average opinion of a couple of analysts.